Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Retro-inverso peptide inhibitors of cell migration, extracellular matrix and endothelial invasion by tumor cells

Retro-inverso peptide inhibitors of cell migration, extracellular matrix and endothelial invasion by tumor cells

US Patent 10836792 · Granted Nov 17, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Long-acting co-agonists of the glucagon and GLP-1 receptors2022
MiRNAs for treatment and in vitro diagnosis of drug resistant tumors2022
Long-acting co-agonists of the glucagon and GLP-1 receptors2020
Immunotherapy against ErbB-3 receptor2020
Co-agonists of the glucagon and GLP-1 receptors2019
Co-agonists of the glucagon and GLP-1 receptors2019
Immunotherapy against ErbB-3 receptor2017
Oxyntomodulin analogs2017
Glucagon/GLP-1 receptor co-agonists2015
Cholesterol derivatives of inhibitors of viral fusion2014
Matrix metalloproteinase 11 vaccine2013
Peptides having pharmacological activity for treating disorders associated with 2013